Cargando…

Association of Plasminogen Activator Inhibitor-Type 1 (-675 4G/5G) Polymorphism with Pre-Eclampsia: Systematic Review

BACKGROUND AND AIMS: Excessive generation of plasminogen activator inhibitor-type 1 (PAI-1) is implicated in the pathogenesis of pre-eclampsia and related conditions. The PAI-1 (−675 4G/5G) promoter polymorphism (rs1799889) affects transcriptional activity and is a putative genetic risk factor for p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morgan, Jessie A., Bombell, Sarah, McGuire, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574018/ https://www.ncbi.nlm.nih.gov/pubmed/23457639 http://dx.doi.org/10.1371/journal.pone.0056907

Ejemplares similares

Association between Plasminogen Activator Inhibitor-1 -675 4G/5G Polymorphism and Sepsis: A Meta-Analysis
por: Li, Li, et al.
Publicado: (2013)

The −675 4G/5G Polymorphism in Plasminogen Activator Inhibitor-1 Gene Is Associated with Risk of Asthma: A Meta-Analysis
por: Nie, Wei, et al.
Publicado: (2012)

Association of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G Promoter Polymorphism with Risk of Keloid in a Chinese Han Population
por: Wang, Yongjie, et al.
Publicado: (2014)

The 4G/5G polymorphism of plasminogen activator inhibitor type 1 is a predictor of allergic cough
por: Tang, Rui, et al.
Publicado: (2023)

Plasminogen activator inhibitor-1 4G/5G gene polymorphism and primary open-angle glaucoma
por: Mossböck, Georg, et al.
Publicado: (2008)

Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis
por: Zhang, Tengyue, et al.
Publicado: (2013)

The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease
por: Katko, Monika, et al.
Publicado: (2021)

PAI-1 -675 4G/5G Polymorphism in Association with Diabetes and Diabetic Complications Susceptibility: a Meta-Analysis Study
por: Xu, Kuanfeng, et al.
Publicado: (2013)

Association Between - 675 ID, 4G/5G PAI-1 Gene Polymorphism and Pregnancy Loss: A Systematic Review
por: Adler, Grazyna, et al.
Publicado: (2018)

Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects
por: Al-Hamodi, Zaid H., et al.
Publicado: (2012)

Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Presenting as Recurrent Ischemic Stroke: The Microthrombi Shower
por: Dayco, John, et al.
Publicado: (2022)

Meta-Analysis of the Association between Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Recurrent Pregnancy Loss
por: Li, Xuejiao, et al.
Publicado: (2015)

Plasminogen Activator Inhibitor-1 4G/5G (rs1799889) Polymorphism in Chinese Patients with Diabetes Mellitus and Hypertension
por: Wang, Ziran, et al.
Publicado: (2023)

Plasminogen activator inhibitor-1 4G/5G polymorphism and dyslipidemia with branch retinal artery occlusion in a young lady
por: Kurtul, Bengi Ece, et al.
Publicado: (2020)

Association of -675 4G/5G PAI-1 and -2518A/G MCP-1 genetic polymorphisms with polycystic ovary syndrome in Kashmiri women: A case control study
por: Yousuf, Syed Douhath, et al.
Publicado: (2022)

Association of pro-fibrinolytic receptor AnnexinA2 with tissue plasminogen activator/Inhibitor-1 in pre-eclampsia
por: Ruikar, Komal, et al.
Publicado: (2023)

Plasminogen Activator Inhibitor-1 4G/5G Gene Polymorphism and Coronary Artery Disease in the Chinese Han Population: A Meta-Analysis
por: Li, Yan-yan
Publicado: (2012)

Association of the 4 g/5 g polymorphism of plasminogen activator inhibitor-1 gene with sudden sensorineural hearing loss. A case control study
por: Cho, Seong Ho, et al.
Publicado: (2012)

Exploring a possible association between the occurrence of the SERPINE1-675 4G/5G (rs1799889) polymorphism and the increased risk of esophageal cancer in the Caucasian population
por: Klimczak-Bitner, Anna Agnieszka, et al.
Publicado: (2021)

Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor VII Arg353-->Gln polymorphism in Korean patients with coronary artery disease.
por: Song, J., et al.
Publicado: (2000)

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study
por: Yousef, Aly A, et al.
Publicado: (2020)

Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis
por: Lorente, L, et al.
Publicado: (2009)

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]
Publicado: (2021)

Is urinary excretion of plasminogen associated with development of pre-eclampsia? An observational, explorative case–control study
por: Nielsen, Lise H, et al.
Publicado: (2019)

Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis
por: Zhang, Xin, et al.
Publicado: (2020)

Pre-eclampsia: the Potential of GSNO Reductase Inhibitors
por: Everett, Thomas R., et al.
Publicado: (2017)

Combined presence of coagulation factor XIII V34L and plasminogen activator inhibitor 1 4G/5G gene polymorphisms significantly contribute to recurrent pregnancy loss in Serbian population
por: Joksic, Ivana, et al.
Publicado: (2020)

Cardiac involvement in pre-eclampsia and eclampsia syndrome
por: Andraos, A, et al.
Publicado: (2004)

Management of Pre-eclampsia and Eclampsia: A Simulation
por: Abraham, Cynthia, et al.
Publicado: (2019)

Molecular association of pathogenetic contributors to pre-eclampsia (pre-eclampsia associome)
por: Glotov, Andrey S, et al.
Publicado: (2015)

Effect of Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator Polymorphisms on Susceptibility to Type 2 Diabetes in Malaysian Subjects
por: Al-Hamodi, Zaid, et al.
Publicado: (2012)

Tissue plasminogen activator and plasminogen activator inhibitor type 1 gene polymorphism in patients with gastric ulcer complicated with bleeding.
por: Kim, Hong-Soo, et al.
Publicado: (2003)

Progression of pre-eclampsia to eclampsia under spinal anaesthesia
por: Ebirim, Longinus N., et al.
Publicado: (2012)

Prevention and management of severe pre-eclampsia/eclampsia in Afghanistan
por: Kim, Young Mi, et al.
Publicado: (2013)

Community perceptions of pre-eclampsia and eclampsia in southern Mozambique
por: Boene, Helena, et al.
Publicado: (2016)

Pre-eclampsia and the risk of retinopathy of prematurity in preterm infants with birth weight <1500 g and/or <31 weeks’ gestation
por: Alshaikh, Belal, et al.
Publicado: (2017)

No Association of SERPINE1 −675 Polymorphism With Sepsis Susceptibility: A Meta-Analysis
por: Shi, Chengfang, et al.
Publicado: (2015)

LEPR c.668A>G polymorphism in a cohort of Sri Lankan women with pre-eclampsia / pregnancy induced hypertension: a case control study
por: Tennekoon, Kamani Hemamala, et al.
Publicado: (2012)

The role of genetics in pre-eclampsia and potential pharmacogenomic interventions
por: Williams, Paula Juliet, et al.
Publicado: (2012)

Pre-Eclampsia and Eclampsia: An Update on the Pharmacological Treatment Applied in Portugal †
por: Peres, Gonçalo Miguel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cn91nsmbr6v76ib2e7hfrf1ghm